Perfusionists may be front line soldiers in fight against Covid-19
Perfusionists may be front line soldiers in fight against Covid-19

Perfusionists may be front line soldiers in fight against Covid-19 [117]

  • Faculty: David Platt, Ph.D
  • Date: March 26th, 2020 2:45 pm
  • CEU’s: 3 CEUs
  • Price: $45
  • Category 1 SDCE CEU
Buy Course
Course Rating:
(0 Reviews)

Latest Reviews

View All

Course description

PerfWeb # 34 - Day 2 
Perfusionists may be front line soldiers in fight against Covid-19
  __________________________________________________________ 
#perfusion #perfusionist #Covid-19
Register for free @ https://perfusioneducation.com 
Follow Us on Twitter:  https://twitter.com/nola_conference __________________________________________________________________   
See Our Schedule: https://perfweb.us/webinar-schedule/  _________________________________________________________________ 
Please visit our sponsor links below:  

Meet Your Instructor

David Platt, Ph.D

David Platt, Ph.D

Dr. David Platt has a PhD in carbohydrate chemistry from the Weizmann Institute of Science in Israel and completed his post-doctoral work at Wayne State University in Michigan. He is a pioneer in designing drugs derived from co-polymers. He has over 30 years of experience in drug development, with over 30 patents, authored 10 journal articles, completed 2 textbooks, CEO of 5 public companies, 3 of which were NASDAQ, and conducted over 30 clinical trials. He was the very first to combine chemotherapy with a co-polymer to target cancer which radically improved the safety profile of the treatments. He coined the name Galectin and was the first to publish in a field of research that now produces over 300 peer reviewed articles annually. His life’s work is embodied in his latest invention called BXT-25 which is an oxygen transport delivery drug that is 5000 times smaller than a red blood cell and is capable of treating stroke, ARDS, and other diseases that have an element of hypoxia within the disease.

Read full bio